Kerry Holford

Analyst Kerry Holford, currently employed at BERENBERG, carries an average stock price target met ratio of 59.44% that have a potential upside of 13.04% achieved within 262 days. Previously, Kerry Holford worked at HSBC, BNP.

Kerry Holford’s has documented 54 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 02-Dec-2025.

Wall Street Analyst Kerry Holford

Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 12/5/2023. The price target of $94.36 was fulfilled within 1 day with a profit of $1.54 (1.61%) receiving and performance score of 16.06.

Average potential price target upside

• of $94.38 (9.04%) on LLY (ELI LILLY AND COMPANY).
• of $11.76 (19.39%) on NVS (NOVARTIS AG ADR).
• of $2.39 (4.09%) on NVO (NOVO NORDISK A/S).